Implications of the Latest Expanded Label of 177Lu-PSMA-617 for Nuclear Medicine Practice.

Pluvicto (lutetium Lu 177 vipivotide tetraxetan) - Novartis

http://www.ncbi.nlm.nih.gov/pubmed/42785945

Frankis G Almaguel; Ken Herrmann; Kevin Courtney; Michael A Gorin; Michael J Morris; Oliver Sartor; Scott Tagawa; Steven P Rowe

Sep 25, 2026